D-Index & Metrics Best Publications

D-Index & Metrics D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines.

Discipline name D-index D-index (Discipline H-index) only includes papers and citation values for an examined discipline in contrast to General H-index which accounts for publications across all disciplines. Citations Publications World Ranking National Ranking
Biology and Biochemistry D-index 40 Citations 12,420 89 World Ranking 16533 National Ranking 308

Overview

What is he best known for?

The fields of study he is best known for:

  • Gene
  • Cytokine
  • Immune system

Karl Frei spends much of his time researching Immunology, Tumor necrosis factor alpha, Cell biology, Molecular biology and Microglia. His studies deal with areas such as Meningitis and Central nervous system as well as Immunology. His Cell biology research incorporates themes from Macrophage, Programmed cell death, Granulocyte macrophage colony-stimulating factor and Granulocyte.

His studies in Molecular biology integrate themes in fields like Apoptosis, Peripheral blood mononuclear cell and Fas ligand. His work deals with themes such as Receptor and Astrocyte, which intersect with Microglia. Karl Frei combines subjects such as B cell and Virology with his study of Lymphocytic choriomeningitis.

His most cited work include:

  • Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity (742 citations)
  • On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases. (640 citations)
  • Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells (598 citations)

What are the main themes of his work throughout his whole career to date?

His primary areas of investigation include Immunology, Cell biology, Tumor necrosis factor alpha, Pathology and Cancer research. He interconnects Meningitis, Macrophage and Cerebrospinal fluid in the investigation of issues within Immunology. His Cell biology study also includes fields such as

  • Astrocyte together with Microglia,
  • Cerebral cortex that connect with fields like Microvessel.

His Tumor necrosis factor alpha study combines topics from a wide range of disciplines, such as Pathogenesis, Glutamate receptor, Apoptosis, Microbiology and Nitric oxide. Karl Frei has included themes like Endothelial stem cell and Epilepsy in his Pathology study. His Glioma research is multidisciplinary, incorporating elements of Molecular biology, Ex vivo and Fas ligand.

He most often published in these fields:

  • Immunology (40.00%)
  • Cell biology (22.22%)
  • Tumor necrosis factor alpha (21.48%)

What were the highlights of his more recent work (between 2012-2020)?

  • Cancer research (17.04%)
  • Glioma (12.59%)
  • Angiogenesis (5.19%)

In recent papers he was focusing on the following fields of study:

His scientific interests lie mostly in Cancer research, Glioma, Angiogenesis, Pathology and Cell biology. His study in Cancer research is interdisciplinary in nature, drawing from both Thymosin beta-4, Transforming growth factor, Transforming growth factor beta and Gene silencing. His research in Glioma intersects with topics in Downregulation and upregulation, Tissue microarray and Cell growth.

His Downregulation and upregulation research is multidisciplinary, incorporating perspectives in Cytokine and Sensitization. The Angiogenesis study combines topics in areas such as Retina, Neuroscience, Neurovascular bundle and Immunology. His study explores the link between Cell biology and topics such as Cerebral cortex that cross with problems in Astrocyte, Human brain, Chemokine and Receptor.

Between 2012 and 2020, his most popular works were:

  • Wiring the Vascular Network with Neural Cues: A CNS Perspective. (81 citations)
  • Nogo-A is a negative regulator of CNS angiogenesis (73 citations)
  • Transforming growth factor-β pathway activity in glioblastoma. (55 citations)

In his most recent research, the most cited papers focused on:

  • Gene
  • Cytokine
  • Immune system

His primary scientific interests are in Cancer research, Angiogenesis, Transforming growth factor beta, Retina and Neuroscience. His biological study spans a wide range of topics, including Neural stem cell, Immunology, Thymosin beta-4, Molecular biology and Gene isoform. His study in the fields of Tumor microenvironment under the domain of Immunology overlaps with other disciplines such as Vascular endothelial growth factor A.

The study incorporates disciplines such as Growth factor, Platelet-derived growth factor receptor, Messenger RNA, Plasminogen activator and SMAD in addition to Transforming growth factor beta. The concepts of his Retina study are interwoven with issues in Neurovascular bundle, Central nervous system and Nervous system. His Neuroscience research incorporates elements of Filopodia and Intracellular, Cell biology.

This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.

Best Publications

Conversion of Membrane-bound Fas(CD95) Ligand to Its Soluble Form Is Associated with Downregulation of Its Proapoptotic Activity and Loss of Liver Toxicity

Pascal Schneider;Nils Holler;Jean-Luc Bodmer;Michael Hahne.
Journal of Experimental Medicine (1998)

946 Citations

On the cellular source and function of interleukin 6 produced in the central nervous system in viral diseases.

Karl Frei;Ursula V. Malipiero;Thomas P. Leist;Rolf M. Zinkernagel.
European Journal of Immunology (1989)

805 Citations

Antigen presentation and tumor cytotoxicity by interferon-γ-treated microglial cells

Karl Frei;Christine Siepl;Peter Groscurth;Stefan Bodmer.
European Journal of Immunology (1987)

741 Citations

Murine brain macrophages induce NMDA receptor mediated neurotoxicity in vitro by secreting glutamate

Daniela Piani;Karl Frei;Kim Quang Do;Michel Cuénod.
Neuroscience Letters (1991)

516 Citations

Immunosuppression and transforming growth factor-beta in glioblastoma. Preferential production of transforming growth factor-beta 2.

S Bodmer;K Strommer;K Frei;C Siepl.
Journal of Immunology (1989)

454 Citations

Toll-like receptor 2-deficient mice are highly susceptible to Streptococcus pneumoniae meningitis because of reduced bacterial clearing and enhanced inflammation.

Hakim Echchannaoui;Karl Frei;Christian Schnell;Stephen L. Leib.
The Journal of Infectious Diseases (2002)

431 Citations

Anti-Fas/APO-1 antibody-mediated apoptosis of cultured human glioma cells. Induction and modulation of sensitivity by cytokines.

Michael Weller;Karl Frei;Peter Groscurth;Peter H. Krammer.
Journal of Clinical Investigation (1994)

424 Citations

Stroma-Derived Interleukin-34 Controls the Development and Maintenance of Langerhans Cells and the Maintenance of Microglia

Melanie Greter;Iva Lelios;Pawel Pelczar;Guillaume Hoeffel.
Immunity (2012)

418 Citations

Increased Secretion of Tumor Necrosis Factor α, Interleukin 1, and Interleukin 6 by Human Mononuclear Cells Exposed to β-Galactoside-specific Lectin from Clinically Applied Mistletoe Extract

Tibor Hajto;Katarina Hostanska;Karl Frei;Christiane Rordorf.
Cancer Research (1990)

415 Citations

T cell suppressor factor from human glioblastoma cells is a 12.5-kd protein closely related to transforming growth factor-beta.

M Wrann;S Bodmer;R de Martin;C Siepl.
The EMBO Journal (1987)

390 Citations

If you think any of the details on this page are incorrect, let us know.

Contact us

Best Scientists Citing Karl Frei

Michael Weller

Michael Weller

University of Zurich

Publications: 123

Adriano Fontana

Adriano Fontana

University of Zurich

Publications: 60

Uwe Koedel

Uwe Koedel

Ludwig-Maximilians-Universität München

Publications: 48

Hans Lassmann

Hans Lassmann

Medical University of Vienna

Publications: 45

Iain L. Campbell

Iain L. Campbell

University of Sydney

Publications: 44

Harald Wajant

Harald Wajant

University of Würzburg

Publications: 43

Pascal Schneider

Pascal Schneider

University of Lausanne

Publications: 38

Georg W. Kreutzberg

Georg W. Kreutzberg

Max Planck Society

Publications: 36

Etty N. Benveniste

Etty N. Benveniste

University of Alabama at Birmingham

Publications: 36

Hans-Walter Pfister

Hans-Walter Pfister

Ludwig-Maximilians-Universität München

Publications: 35

Gregg B. Fields

Gregg B. Fields

Florida Atlantic University

Publications: 35

Marco Prinz

Marco Prinz

University of Freiburg

Publications: 34

Andreas Strasser

Andreas Strasser

Walter and Eliza Hall Institute of Medical Research

Publications: 33

Wolfgang J. Streit

Wolfgang J. Streit

University of Florida

Publications: 30

Richard M. Ransohoff

Richard M. Ransohoff

Harvard University

Publications: 30

Jack P. Antel

Jack P. Antel

McGill University

Publications: 28

Trending Scientists

Aggelos Kiayias

Aggelos Kiayias

University of Edinburgh

John Krogstie

John Krogstie

Norwegian University of Science and Technology

Gerhard Neumann

Gerhard Neumann

Karlsruhe Institute of Technology

Ji Liu

Ji Liu

University of Rochester

Kenneth D. Karlin

Kenneth D. Karlin

Johns Hopkins University

Andrew G. Myers

Andrew G. Myers

Harvard University

Pramod S. Patil

Pramod S. Patil

Shivaji University

Hartwig H. Geiger

Hartwig H. Geiger

University of Hohenheim

Gerald L. Kooyman

Gerald L. Kooyman

University of California, San Diego

Ralf G. Dietzgen

Ralf G. Dietzgen

University of Queensland

Jun Aruga

Jun Aruga

Nagasaki University

Jun Zheng

Jun Zheng

Nanjing University of Information Science and Technology

David J. Schretlen

David J. Schretlen

Johns Hopkins University

Fergus Shanahan

Fergus Shanahan

National University of Ireland

Ernesto Panadero

Ernesto Panadero

University of Deusto

Something went wrong. Please try again later.